Journal of Comparative Effectiveness Research (Mar 2023)

Evaluation of hypercholesterolemia management in at-risk patients by cardiologists in France: a case vignette-based study

  • Jean Ferrieres,
  • Eric Bruckert,
  • Michel Farnier,
  • Michel Krempf,
  • Jean-Jacques Mourad,
  • Baptiste Roux,
  • Francois Schiele

DOI
https://doi.org/10.57264/cer-2022-0181
Journal volume & issue
Vol. 12, no. 4

Abstract

Read online

Aim: This online interactive survey investigated lipid-lowering approaches of French cardiologists in highand very high-cardiovascular risk patients with hypercholesterolemia. Materials & methods: Physicians assessed three hypothetical patients at three clinic visits, and selected the patients’ cardiovascular risk category, target low-density lipoprotein cholesterol (LDL-C) and treatment. Results: A total of 162 physicians completed 480 risk assessments; 58% of assessments correctly categorized the hypothetical patients. Most physicians chose the correct LDL-C target for one of the very high-risk patients, but higherthan- recommended targets were selected for the other very high-risk patient and the high-risk patient. Statins were the most commonly chosen treatment. Conclusion: French cardiologists often underestimate cardiovascular risk in patients with hypercholesterolemia, select a higher-than-recommended LDL-C target and prescribe less intensive treatment than that recommended by guidelines.

Keywords